Work

Safety of Partial and Radical Nephrectomy for Complex Locally Advanced Renal Cell Carcinoma After Neo-Adjuvant Immune Checkpoint Inhibition: Analysis From a Phase 1b Trial (Durvalumab +/- Tremelimumab)

Year: 2025

Type: article

Source: Urology

DOI: 10.1016/j.urology.2025.05.023

Authors: Jason M. Scovell, Brian I. Rini, Venkatesh Krishnamurthi, Jihad Kaouk, Christopher J. Weight, Moshe C. Ornstein, Georges Pascal-Haber, Mohamed Eltemamy, Shilpa Gupta, Steven C. Campbell, Joseph Zabell

Institutions: Cleveland Clinic, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, University of Minnesota

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca United States, AstraZeneca

OpenAlex ID: W4410760574

FWCI: 0.608

Cites: 18

Cited by: 1

Related to: 10